Essa Pharma
2009
FOUNDED
PUBLIC
STATUS
11-20
EMPLOYEES
EPI
STOCK SYMBOL
1
INVESTMENTS
$5.87
SHARE PRICE
(As of Friday Closing)
Description
ESSA Pharma Inc is a pharmaceutical company. The company is in preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs which selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.
Website
Formerly Known As
ESSA Pharmaceuticals
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Stock Exchange
TSX
Primary Office
- 999 West Broadway Street
- Suite 720
- Vancouver, British Columbia V5Z 1K5
- Canada
+1 (778) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Essa Pharma’s full profile, request a free trial.
Essa Pharma Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $1.43 - $6.04 | $122M | $5.77 | -$1.88 | 4.88K | 20.8M |
Essa Pharma Financials Summary
|
In Thousands,
USD |
TTM
30-Jun-2019
|
FY 2018
30-Sep-2018
|
FY 2017
30-Sep-2017
|
FY 2016
30-Sep-2016
|
|---|---|---|---|---|
| Enterprise Value | 13,085 | 6,916 | 9,053 | 70,613 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (11,009) | (10,699) | (3,552) | (11,984) |
| Net Income | (11,719) | (11,629) | (4,499) | (13,140) |
| Total Assets | 7,072 | 16,017 | 5,607 | 10,403 |
| Total Debt | 4,393 | 6,317 | 7,960 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Essa Pharma Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Essa Pharma‘s full profile, request access.
Request full access to PitchBookEssa Pharma Competitors (25)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Xenetic Bioscience | Corporation | Lexington, MA | 0 | 0000 | 00000000 | 0000 |
| 00000000 000000000 | Formerly VC-backed | Allschwil, Switzerland | 0000 | 00000 | 000000&0 | 00000 |
| 0000 00000000 | Formerly VC-backed | Stamford, CT | 00 | 00000 | 000000&0 | 00000 |
| 000000 | Venture Capital-Backed | San Diego, CA | 0 | 00.000 | 0000000000 0 | 00.000 |
| 000000 | Corporate Backed or Acquired | Wilmington, DE | 0000 | 00000000000 |
Essa Pharma Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 000000000000 | 31-Jul-2019 | 000000000000000000 | 000.00 | Drug Discovery |
Essa Pharma Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 00000 000000000000 | Drug Discovery | Malvern, PA | 0000 |
Essa Pharma Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Essa Pharma‘s full profile, request access.
Request full access to PitchBookEssa Pharma Executive Team (8)
3 Former Executives
You’re viewing 5 of 8 executives. Get the full list »Essa Pharma Board Members (8)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 00000 000000000 00 | Essa Pharma | Chief Executive Officer & Board Member | 000 0000 | |
| 00000000 000000 | Self | Board Member | 000 0000 | |
| 0000 000000 | Self | Board Member | 000 0000 | |
| 0000000 00000000 | Self | Chairman & Board Member | 000 0000 | |
| 00000 0000000 00 | Blackstone Life Sciences | Board Member | 000 0000 |
3 Former Board Members
You’re viewing 5 of 8 board members. Get the full list »